Another great way to get highlights from the ACR 2020 meeting - listen in to faculty reports and overviews.
All News
ACR20 Day 1.2 Podcast
Another great way to get highlights from the ACR 2020 meeting - listen in to faculty reports and overviews.
Read Article
Decreasing immunogenicity, improving efficacy of pegloticase in gout
At #ACR20 three different medications are reviewed in different studies to decrease the immunogenicity of pegloticase – Methotrexate, Azathioprine and Mycophenolate Mofetil.
Read Article
Fascinating and engaging talk by Dr. Kastner on the discovery of VEXAS using a genotype-first strategy. Definitely one to go back and watch if you missed it! #ACR20 https://t.co/D090V7HiG2
E. Sloan esloanmd ( View Tweet)
Dan Kastner giving an absolute tour de force of the discovery of VEXAS in autoinflammatory diseases: mechanisms and management session now. If you aren't listening, watch it back! #ACR20 @rheumnow https://t.co/zell5e2Brt
Richard Conway RichardPAConway ( View Tweet)
Older patients with polypharmacy are at ⬆ risk for drug-drug reactions and adverse effects. @RheumNow #ACR20 https://t.co/uKsYO9B8PZ
sheila RHEUMarampa ( View Tweet)
Management of elderly patients with rheumatic diseases. Dr Rajasimhan. #ACR20 @RheumNow. Also we are near of first therapeutic recommendations of elderly #sjogren syndrome @ramos_casals @p_brito_zeron https://t.co/yjGrSTWV1K
Sole RetamozoSole ( View Tweet)
Ultrasound to assess synovial-entheses junction correlated with clinical findings Abs#0311
Do you use MSK US in your clinic? @RheumNow #ACR20
Robert B Chao, MD doctorRBC ( View Tweet)
Dr Khanna presents RECIPE RCT of MMF to reduce immunogenicity of pegloticase. Sustained urate response ≤6mg/dL at 24 weeks 68% with MMF compared to 30% in placebo. @rheumnow #ACR20 Abstr#952 #ACRbest https://t.co/64nN5AqK3W
Richard Conway RichardPAConway ( View Tweet)
With the COVID-19 pandemic has this changed our acceptance of telemedicine (TM)? This study from 2018 suggest that tech may be limited to certain demographics and follow up patients more likely to accept TM @RheumNow #ACR20 Abstr#0569
Dr. Antoni Chan synovialjoints ( View Tweet)
Excellent session on #autoinflammatory syndromes #SAPHO syndrome -IL-1 role in disease pathogenesis and something that I ve not come across clinically #Majeed Syndrome @RheumNow #ACR20 #3S038 https://t.co/vnfjPD6Zx9
Bella Mehta bella_mehta ( View Tweet)
Dr. Subedi: "we need to stop blaming just the age" in geriatric patients for adherence. Busy, middle aged patients more likely than geriatrics to have adherence issues. 3S040. Pharmaco Pearls for Older Rheum Pt. #ACR20 @RheumNow https://t.co/3UAkjRNT3u
Eric Dein ejdein1 ( View Tweet)
Dr Merriman presents on role of diet in gout. It is minor, especially compared to urate lowering therapy. Average attributable fraction approximately 10-fold greater for ULT than following healthy-eating guidelines. @rheumnow #ACR20 Abstr#951 https://t.co/1tftswOEJq
Richard Conway RichardPAConway ( View Tweet)
Time-trend analysis in hospitalised #infection in #lupus
-Incr. rate of hospitalised infections over time
-#Sepsis surpassed #pneumonia as most common hospitalised infection in 2011-12; twice as many sepsis vs pneumonia by 2015-16
Abs#0980 #ACR20 @RheumNow
https://t.co/M8xbMDFUTS https://t.co/ShogvxbhzN
Mrinalini Dey DrMiniDey ( View Tweet)
Dr Cai presents risk of CVD in gout in study 450,000 patients. Gout was independently associated with an increased risk of CVD events HR = 1.24 for women; 1.21 for men. @rheumnow #ACR20 Abstr#950 #ACRbest https://t.co/089aKtN5a7
Richard Conway RichardPAConway ( View Tweet)
Racial disparity in SSc-ILD pts treated with MMF?
1️⃣Early initiation of MMF significantly slowed ⬇️ of FVC%
2️⃣No difference in MMF efficacy between African-Americans and non-AA
3️⃣AA had baseline lower FVC%
@RheumNow #ACR20 Abs0929 https://t.co/rtsbe7OCvA
Robert B Chao, MD doctorRBC ( View Tweet)
@RheumNow #acr20 abs0876 gender differences AS and nrSpA from 3 RCT IXE trials: F more likely to be older, have more nocturnal BP, peripheral pain&fatigue. M have higher CRP & +HLAB27. Ant uveitis > in M w/AS (23.8% vs. 17.9%) but > common in F w/ nr-axSpA (15.2% vs. 7.1%). https://t.co/HZa7AfWbBh
Olga Petryna DrPetryna ( View Tweet)
The RheumNow podcast on #ACR20 Day 1 Part II is now available for download. Follow the link below to listen in or find us on Apple.
https://t.co/W6EMQiF9Rf https://t.co/ZlFDiVgAKl
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr Fauci assured the medical community the NIH #COVID19 reccs can be trusted and is a living document that we should access to care for patients with CV19 #ACR20 @RheumNow https://t.co/GrJUvdFFhk
k dao KDAO2011 ( View Tweet)
Such an honor to have @DrFaucis1 at #ACR20! 👏👏👏 He reminds us of the fundamentals to prevent acquiring and transmitting #SARSCoV2 @RheumNow https://t.co/Xu4F8q64RJ
sheila RHEUMarampa ( View Tweet)